10x Genomics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

10X Genomics develops genome sequencing software and hardware products that enable researchers to discover inaccessible genomic information. Read more

10X Genomics develops genome sequencing software and hardware products that enable researchers to discover inaccessible genomic information. Read more

Serge Saxonov's photo - Co-Founder & CEO of 10x Genomics

Co-Founder & CEO

Serge Saxonov

CEO Approval Rating

87/100

Founded:

2012

Status:

PublicNASDAQTXG

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

GenapSys is perceived as one of 10x Genomics's biggest rivals. GenapSys was founded in 2010, and is headquartered in Redwood City, California. GenapSys is in the Health Care Equipment industry. GenapSys generates $225.5M less revenue vs. 10x Genomics.

PacBio is a top competitor of 10x Genomics. PacBio is a Public company that was founded in 2004 in Menlo Park, California. Like 10x Genomics, PacBio also operates in the Biotechnology space. Compared to 10x Genomics, PacBio has 309 fewer employees.

Fluidigm is 10x Genomics's #3 rival. Fluidigm is headquartered in South San Francisco, California, and was founded in 1999. Like 10x Genomics, Fluidigm also works within the Biotechnology sector. Fluidigm generates 48% the revenue of 10x Genomics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Fasteris a competitor of 10x Genomics?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$231.8M

10x Genomics's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 818.2M. Over the last three quarters, 10x Genomics's revenue has decreased by 68.8%. Specifically, in Q2 2020's revenue was $42.9M; in Q1 2020, it was $71.9M; in Q4 2019, it was $137.4M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
ReadCoor, Inc.

Oct 2020

Source »
$350M
ReadCoor develops a spatial sequencing platform that provides disease diagnosis survey and molecular insights for the healthcare sector.
Cartana AB

Aug 2020

Source »
undisclosed
Cartana is a biotechnology company that provides tissue cell mapping services for the healthcare sector.
Spatial Transcriptomics AB

Dec 2018

Source »
undisclosed
Spatial Transcriptomics is a provider of tissue-based gene expression analysis for research and diagnostics.

These are all the companies that 10x Genomics has acquired. 10x Genomics has acquired 3 companies and its latest acquisition was ReadCoor, Inc. in Oct 2020. ReadCoor develops a spatial sequencing platform that provides disease diagnosis survey and molecular insights for the healthcare sector.

10x Genomics Funding History

$0$55.5M$110.5M$235.5M$660.5M

Since 10x Genomics was founded in 2012, it has participated in 7 rounds of funding. In total 10x Genomics has raised $660.5M. 10x Genomics' last funding round was on Sep 2019 for a total of $390.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Sep 2019
$390M

Series D
Jan 2019
$35M
Debt
Apr 2018
$75M
Series D
Apr 2018
$50M
Series C
Mar 2016
$55M

Since 10x Genomics was founded in 2012, it has participated in 7 rounds of funding. In total 10x Genomics has raised $660.5M. 10x Genomics' last funding round was on Sep 2019 for a total of $390.0M

Investments

No recent investments found related to 10x Genomics

These are all the companies that 10x Genomics has invested in. 10x Genomics has invested 3 companies and its latest investment was ReadCoor, Inc. in Oct 2020. ReadCoor develops a spatial sequencing platform that provides disease diagnosis survey and molecular insights for the healthcare sector.

10x Genomics News

October 12, 2020Zolmax News

10x Genomics (NYSE:TXG) Reaches New 52-Week High at $157.66

10x Genomics (NYSE:TXG)'s stock price reached a new 52-week high during trading on Monday . The compa... See more »
October 8, 2020BioSpace

10x Genomics Enters In Situ Analysis Market with Recent Acquisitions

10X Genomics just agreed to acquire ReadCoor, Inc., an innovator in the nascent field of in situ tech... See more »
October 7, 2020Global Legal Chronicle

10x Genomics' $41.2 Million Acquisition of CartaNA

Latham & Watkins LLP represented 10x Genomics, Inc. in the transaction. 10x Genomics, Inc. (Nasdaq: T... See more »
October 7, 2020Global Legal Chronicle

10x Genomics' $350 Million Acquisition of ReadCoor

Latham & Watkins LLP represented 10x Genomics in the transaction. 10x Genomics, Inc. (Nasdaq: TXG) ha... See more »
October 7, 2020Pulse2.0

Why 10X Genomics (TXG) Acquired ReadCoor And CartaNA AB

10X Genomics Inc (NASDAQ: TXG) recently announced it entered into a definitive agreement to buy ReadC... See more »
October 6, 2020Benzinga

10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions.

10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions.... See more »
September 20, 2020ChinaPulse

Point72 Hong Kong Ltd Makes New $28,000 Investment in 10x Genomics (NYSE:TXG)

Point72 Hong Kong Ltd purchased a new position in shares of 10x Genomics (NYSE:TXG) during the 2nd qu... See more »

10x Genomics Press Releases

May 20, 2020centralcharts

10x Genomics Launches Targeted Gene Expression Solution

PLEASANTON, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Building on its earlier reveal at the Advances i... See more »
May 5, 2020centralcharts

10x Genomics to Present at the BofA Securities 2020 Healthcare Conference

PLEASANTON, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the c... See more »
February 25, 2020centralcharts

10x Genomics to Present at the 40th Annual Cowen Health Care Conference

PLEASANTON, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announc... See more »
February 24, 2020centralcharts

10x Genomics Debuts Range of New Products at AGBT

PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- 10x Genomics , Inc. (Nasdaq: TXG) today announc... See more »
January 7, 2019PR Newswire

10x Genomics Lands New Financing

PLEASANTON, Calif., Jan. 7, 2019 /PRNewswire/ -- 10x Genomics, today announced $35 million in funding... See more »
December 10, 2018StreetInsider

10x Genomics Acquires Spatial Transcriptomics

10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in... See more »
November 14, 2018PRWeb

Webinar Sponsored by Illumina and 10x Genomics Will Demonstrate How Single-Cell RNA Sequencing Enables a Deep Dive Into Mechanisms Responsible for Health and Disease

In this educational webinar, one of the speakers, Dr. Bernard Thienpont, Assistant Professor, Faculty... See more »

10x Genomics Videos

June 17, 202010X Genomics Youtube Channel

"06 CRISPR" on YOUTUBE

June 17, 202010X Genomics Youtube Channel

"05 " on YOUTUBE

June 10, 202010X Genomics Youtube Channel

"10 Visium | " on YOUTUBE

June 10, 202010X Genomics Youtube Channel

"08 Visium | " on YOUTUBE

June 10, 202010X Genomics Youtube Channel

"09 Visium | " on YOUTUBE

Social Statistics

Headquarters

6230 Stoneridge Mall Road

Pleasanton, California94588-3260

1-925-401-7300

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

10X Genomics develops genome sequencing software and hardware products that enable researchers to discover inaccessible genomic information. 10x Genomics was founded in 2012. 10x Genomics' headquarters is located in Pleasanton, California, USA 94588-3...

CEO

10x Genomics's Co-Founder & CEO, Serge Saxonov, currently has an approval rating of 87%. 10x Genomics's primary competitors are GenapSys, PacBio & Fluidigm.

Website

10xgenomics.com

Frequently Asked Questions about 10x Genomics

  1. When was 10x Genomics founded?

    10x Genomics was founded in 2012
  2. Who is 10x Genomics's CEO?

    10x Genomics's CEO is Serge Saxonov
  3. How much revenue does 10x Genomics generate?

    10x Genomics generates $231.8M in revenue
  4. How much funding does 10x Genomics have?

    10x Genomics has historically raised $660.5M in funding
  1. Where is 10x Genomics's headquarters?

    10x Genomics's headquarters is in Pleasanton California, USA
  2. How many employees does 10x Genomics have?

    10x Genomics has 713 employees
  3. What sector does 10x Genomics operate in?

    10x Genomics is in Biotechnology
  4. Who are 10x Genomics's competitors?

    10x Genomics's top competitors are GenapSys, PacBio, Fluidigm